There are currently 82,000 incident cases of RCC annually in the United States (account for 3–5% of cancers), with 15,000 deaths annually in the United States. The overall 5-year mortality risk is ~30 ...

Kiromic BioPharma (KRBP) reported continued efficacy results from the 10-month follow-up visit for the fourth patient enrolled in its ...

Greatwall, a conserved MAST-like kinase with crucial mitotic entry functions, is curiously absent in worms. Here, the single ...

We list the best free Gantt chart software, to make it simple and easy to follow the progress of project management schedules, without a paid-for subscription. A Gantt chart is a very important ...

The below chart from UCSF Benioff Children’s Hospital outlines the normal range of beats per minute for resting heart rate, based on age. Target heart rate refers to a range of heart beats per ...

by British and Irish artists, based on sales in the UK of downloads, CDs, vinyl and other formats, plus streams. Compiled by the Official Charts Company.

TMED2 knockdown reduced cell proliferation, increased the apoptosis rate in SCC-4 cells, and led to a higher proportion of cells in the G0/G1 phase and a lower proportion ... apoptosis rate, and cell ...

The three phases of schizophrenia are the prodromal, active, and residual phases. Symptoms of schizophrenia can depend on the phase. Early symptoms of schizophrenia may be similar to other conditions.

Administration of hSPAR or hSPAR-C significantly impedes breast cancer cell proliferation and tumor growth in xenograft models. These findings define hSPAR as an intrinsic control factor for cellular ...

It feels like the Splinter Cell remake has been on its way for a while now, which isn't helped by the fact it's been over three years since we heard anything official about the game. From what we ...

oxygen − dependent on its exposure duration − affects NSC expansion by regulating cell cycle length. Of note, already an exposure to atmospheric oxygen levels for a few hours dramatically shifts NSCs ...

Exploratory study of TAS-102 combined with intermittent administration of fruquintinib in the treatment of third-line metastatic colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...